Skip to main content

Table 2 (abstract P035). See text for description

From: 39th International Symposium on Intensive Care and Emergency Medicine

Drug-related adverse events (Grade ≥ 2) Grade 480 mg nivolumab (n=5) 960 mg nivolumab (n=8)
Alanine aminotransferase increased 4 1 (20.0)* 0 (0.0)
Aspartate aminotransferase increased 3 1 (20.0)* 0 (0.0)
Pruritus 2 1 (20.0)* 0 (0.0)
Rash 2 1 (20.0)* 0 (0.0)
Organizing pneumonia 2 1 (20.0)* 0 (0.0)
  1. n (%), *All drug-related adverse events were observed in the same patient